Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Cisco who wrote (1455)	2/20/1998 10:04:00 AM
From: Sigmund	Read Replies (2) \| Respond to of 1894

<The key question that we do not have the answer to is what are the conditions that NASDAQ is requiring AccuMed to meet in order to be excepted from the initial listing requirement to the Small Cap NASDAQ? If they meet these requirements, they should easily be able to retain their listing until they have the earnings to return to the National NASDAQ. I believe the shareholders have a right to know what the conditions are!!! If anyone talks to AccuMed today, please ask them that question.> I agree that this is one of two or possibly three key questions. The second question is how ACMIC plans to meet these requirements. I think this is another example of the stock price being pressured by the company's reluctance to share information with shareholders. Bad news is hard to take but uncertainty is usually worse than the actual news. Some may know what is going on and these people have an unfair advantage over others. Why the company chooses to keep the ordinary shareholder in the dark is a potential third question.